Lupin Receives Approval from U.S. FDA for Efinaconazole Topical Solution
Lupin Limited today announced that it has received approval from the US FDA for its Abbreviated ...
Read moreLupin Limited today announced that it has received approval from the US FDA for its Abbreviated ...
Read moreLupin today announced the launch of Sevelamer Hydrochloride Tablets, 800 mg, having received an approval from ...
Read moreDr. Fabrice Egros to assume Corporate Development responsibilities as President, Corporate Development & Growth Markets Dr. ...
Read moreLupin Pharmaceuticals Inc., announced that the U.S. Food and Drug Administration has approved the company’s supplemental ...
Read moreLupin Limited announced today that it has entered into a distribution agreement with Medis for Lupin's ...
Read moreLupin Limited today announced that it has received approval from the United States Food and Drug ...
Read moreLupin received approval for its Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, from U.S. ...
Read moreLupin announced the launch of its Digital Asthma Educator platform. The platform guides asthma patients on ...
Read moreLupin Limited announced the launch of the authorized generic version of Brovana® (arformoterol tartrate) Inhalation Solution ...
Read moreLupin Limited announced that the U.S. FDA has accepted the Biologics License Application (BLA) for its ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.